1. Why We Need Postmortem Analysis of Cardiac Implantable Electronic Devices
- Author
-
Thorsten Jentzsch, Patrick J. Laberke, Christine Bartsch, Sabrina Mauf, Michael J. Thali, University of Zurich, and Mauf, Sabrina
- Subjects
Pacemaker, Artificial ,medicine.medical_specialty ,Forensic pathology ,medicine.medical_treatment ,Patient demographics ,340 Law ,610 Medicine & health ,Autopsy ,030204 cardiovascular system & hematology ,Pathology and Forensic Medicine ,03 medical and health sciences ,0302 clinical medicine ,1311 Genetics ,Cause of Death ,Genetics ,medicine ,Humans ,030216 legal & forensic medicine ,Cause of death ,business.industry ,Arrhythmias, Cardiac ,Heart ,Small sample ,Implantable cardioverter-defibrillator ,10218 Institute of Legal Medicine ,Defibrillators, Implantable ,Time of death ,Surgery ,2734 Pathology and Forensic Medicine ,Death ,10021 Department of Trauma Surgery ,Increased risk ,Emergency medicine ,business - Abstract
The prevalence of cardiac implantable electronic devices (CIEDs), pacemakers and implantable cardioverter defibrillators (ICDs) is increasing. However, postmortem analysis of CIEDs is not performed routinely. Fourteen consecutive CIEDs were analyzed. The indication for and date of implantation, technical data, CIED reprogramming, heart rhythm disturbances, patient demographics and medical consultations were investigated. Death during the first year after implantation was seen in 54%, whereof 71% consulted a physician within 10 days before death. The time of death was attributed to a particular day in 29%. There was a relationship between CIEDs and cause/manner of death in 50%. Although limited by a small sample size, this study advocates the routine postmortem CIED analysis for forensic and clinical purposes in selected cases. Patients with CIEDs seem to show an increased risk of death during the first year after implantation. The analysis of CIEDs can be helpful in evaluating the time/cause/manner of death.
- Published
- 2016